Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 53NIH 7NETWORK 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 14Myeloid 7Lymphoid 6CNS 4Sarcoma 3Other neoplasm 2Classical hematology 2Other solid neoplasm 1

Conditions

Myelodysplastic Syndromes 2Leukemia, Myelomonocytic, Chronic 2Leukemia 2Anemia, Refractory, with Excess of Blasts 2Congenital Abnormalities 1

Interventions

Radiotherapy 5Methotrexate 4Cytarabine 4Cyclophosphamide 4Epoetin Alfa 3Daunorubicin 3Cyclosporine 3Thioguanine 2Peripheral Blood Stem Cell Transplantation 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Dexamethasone 2Cisplatin 2Busulfan 2Asparaginase 2zosuquidar trihydrochloride 1thymoglobulin 1sargramostim 1merphos 1hydrocortisone hemisuccinate 1fludarabine 1Whole-Body Irradiation 1Vincristine 1Thrombopoietin 1Stem Cell Transplantation 1Prednisone 1Photopheresis 1Pentostatin 1Mycophenolic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Busulfan × Classical hematology × Clear all
NCT00005866 2015-03-06

S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia

SWOG Cancer Research Network

Phase 3 Completed
240 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT00077116 2012-07-16

Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
31 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡